Tag: Clinical Research
-
Rochester Regional Health Unveils Free GenoWell Genetic Screening Program
Rochester Regional Health has announced the launch of GenoWell, a complimentary genetic screening program and research platform designed to help participants understand how their DNA influences various health outcomes. The initiative, unveiled in Gates, N.Y., marks a notable step forward in personalized medicine, offering participants insights that could inform preventive strategies, lifestyle choices, and potential…
-
GenoWell Genetic Screening Launch by Rochester Regional Health
Rochester Regional Health Introduces GenoWell: A Free Genetic Screening Initiative Gates, N.Y. — Rochester Regional Health is expanding its commitment to preventive care with a new program and research tool called GenoWell. The initiative offers free genetic screening to participants, aiming to illuminate how individual DNA variants influence health outcomes. By combining genetic data with…
-
Breakthrough Grant Advances First Study of Prefrontal Stimulation for Severe Bipolar Disorder
Groundbreaking Investment to Explore Neuromodulation in Bipolar Disorder A University of Minnesota Medical School research team, led by Dr. Ziad Nahas, has secured a $4.4 million grant to pursue a pioneering, first-in-the-world study of prefrontal cortical stimulation as a potential treatment for severe bipolar disorder. The funding comes from Breakthrough Discoveries, signaling strong confidence in…
-
Inflammasome Proteins Offer New Path in Pediatric Traumatic Brain Injury Assessment
Breakthrough in Pediatric TBI Evaluation: Biomarkers ASC and caspase-1 A new study published in Nature Pediatric Research highlights a promising biomarker-based approach to assessing pediatric traumatic brain injury (TBI). Led by Dr. Jennifer Muñoz Pareja, the research examines serum inflammasome proteins ASC and caspase-1, revealing that their levels rise significantly in children with TBI and…
-
Ketamine for First Responders: Unregulated Care Hurdles
Overview: Ketamine and the push for faster access to mental health care Combining psychotherapy with low-dose ketamine is an emerging approach aimed at treating severe depression and post-traumatic stress, especially for groups exposed to high trauma, such as police officers and firefighters. While early results have drawn attention for rapid symptom relief, the field remains…
-
Can a new blood test really detect ME/CFS? An expert unpacks new research
New blood test for ME/CFS: exciting but early days Researchers in the United Kingdom say they have developed a blood test that might diagnose myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with about 96% overall accuracy. If validated in larger groups, this could be the first objective tool to support the long, often frustrating process of ME/CFS…
-
Can a New Blood Test Detect ME/CFS? An Expert Breaks Down the Research
Can a new blood test truly diagnose ME/CFS? In the United Kingdom, researchers say they’ve developed a blood test that could diagnose myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with about 96% overall accuracy. If validated in larger studies, this approach could be a game changer for a condition that has long eluded a reliable diagnostic tool.…
-
Cleveland Clinic Team Uncovers Genetic Link to Osteosarcoma
Groundbreaking discovery ties SMARCAL1 gene to pediatric osteosarcoma A team at Cleveland Clinic Children’s has identified a genetic factor that may increase the risk of developing osteosarcoma, the most common malignant bone tumor in children and young adults. The study, recently published in the Journal of Clinical Oncology, analyzed genetic data from nearly 6,000 children…
-
New Painkillers Could Separate Pain Relief from Inflammation: A Potential Breakthrough
Rewriting Pain Management: A New Strategy Emerges Current non-steroidal anti-inflammatory drugs (NSAIDs) are effective at easing pain by blocking prostaglandins — chemicals involved in inflammation. While this helps reduce discomfort, it can also hinder the body’s healing processes and bring a range of side effects, from stomach issues to heart and kidney risks. A recent…
-
We told you we weren’t hysterical. Now the science is in
New evidence reshapes the understanding of depression A landmark international study published in Nature Communications is prompting a rethink on how depressive disorders are understood and treated. Led by researchers at QMIR Berghofer Medical Research Institute in Queensland, the work analyzed the DNA of about 200,000 individuals diagnosed with major depressive disorder across Australia, Europe,…